1. Home
  2. MYFW vs GBIO Comparison

MYFW vs GBIO Comparison

Compare MYFW & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYFW
  • GBIO
  • Stock Information
  • Founded
  • MYFW 2002
  • GBIO 2016
  • Country
  • MYFW United States
  • GBIO United States
  • Employees
  • MYFW N/A
  • GBIO N/A
  • Industry
  • MYFW Major Banks
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYFW Finance
  • GBIO Health Care
  • Exchange
  • MYFW Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • MYFW 184.7M
  • GBIO 64.8M
  • IPO Year
  • MYFW 2018
  • GBIO 2020
  • Fundamental
  • Price
  • MYFW $17.68
  • GBIO $0.88
  • Analyst Decision
  • MYFW Buy
  • GBIO Strong Buy
  • Analyst Count
  • MYFW 3
  • GBIO 2
  • Target Price
  • MYFW $22.33
  • GBIO $6.50
  • AVG Volume (30 Days)
  • MYFW 19.9K
  • GBIO 581.0K
  • Earning Date
  • MYFW 01-23-2025
  • GBIO 03-05-2025
  • Dividend Yield
  • MYFW N/A
  • GBIO N/A
  • EPS Growth
  • MYFW N/A
  • GBIO N/A
  • EPS
  • MYFW 0.26
  • GBIO N/A
  • Revenue
  • MYFW $79,649,000.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • MYFW N/A
  • GBIO $212.74
  • Revenue Next Year
  • MYFW $12.86
  • GBIO N/A
  • P/E Ratio
  • MYFW $68.15
  • GBIO N/A
  • Revenue Growth
  • MYFW N/A
  • GBIO 514.08
  • 52 Week Low
  • MYFW $12.84
  • GBIO $0.75
  • 52 Week High
  • MYFW $22.32
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • MYFW 27.46
  • GBIO 28.66
  • Support Level
  • MYFW $17.10
  • GBIO $0.85
  • Resistance Level
  • MYFW $19.41
  • GBIO $1.01
  • Average True Range (ATR)
  • MYFW 0.66
  • GBIO 0.12
  • MACD
  • MYFW -0.18
  • GBIO 0.00
  • Stochastic Oscillator
  • MYFW 20.49
  • GBIO 7.50

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: